| View |
LRV2024-05-16-0203
|
HEPATITIS A (INACTIVATED) VACCINE (ADSORBED)
|
HAVRIX 720
|
BR-1303
|
AHAVC161A
|
Packaging Lot (Box and PFS): AHAVC161AA; (Needle): 2210017
|
30-Jun-26
|
21 May 2024
|
| View |
LRV2024-08-07-0365
|
TETANUS AND DIPHTHERIA TOXOIDS ADSORBED COMBINED WITH COMPONENT ACELLULAR PERTUSSIS VACCINE
|
ADACEL
|
BR-613
|
2CA82
|
Packaging Lot (Box and Vial): 2CA82C1
|
30-Jun-26
|
14 August 2024
|
| View |
LRV2024-09-12-0423
|
HUMAN NORMAL IMMUNOGLOBULIN (IGIV)
|
GAMMA I.V.
|
BR-636
|
A03324016
|
Packing Lot (Box and Vial): A03324016
|
30-Jun-26
|
16 September 2024
|
| View |
LRV2024-09-17-0430
|
HUMAN NORMAL IMMUNOGLOBULIN (IGIV)
|
GAMMA I.V.
|
BR-636
|
A03324015
|
Packaging Lot (Box and Vial): A03324015
|
30-Jun-26
|
19 September 2024
|
| View |
LRV2024-09-26-0440
|
ANTI-RABIES SERUM (EQUINE)
|
EQUIRAB
|
BR-676
|
A06824019
|
Packaging Lot (Box and Vial): A06824019
|
30-Jun-26
|
01 October 2024
|
| View |
LRV2024-09-26-0441
|
HUMAN NORMAL IMMUNOGLOBULIN (IGIV)
|
GAMMA I.V.
|
BR-636
|
A03324018
|
Packaging Lot (Box and Vial): A03324018
|
30-Jun-26
|
01 October 2024
|
| View |
LRV2024-09-26-0442
|
HUMAN NORMAL IMMUNOGLOBULIN (IGIV)
|
GAMMA I.V.
|
BR-636
|
A03324017
|
Packaging Lot (Box and Vial): A03324017
|
30-Jun-26
|
01 October 2024
|
| View |
LRV2024-09-27-0444
|
ANTI-RABIES SERUM (EQUINE)
|
EQUIRAB
|
BR-676
|
A06824020
|
Packaging Lot (Box and Vial): A06824020
|
30-Jun-26
|
03 October 2024
|
| View |
LRV2024-10-29-0474
|
MEASLES, MUMPS AND RUBELLA VACCINE (LIVE, ATTENUATED)
|
TRESIVAC
|
BR-434
|
0133N125A
|
Packaging Lot (Box and Vial): 0133N125A
|
30-Jun-26
|
05 November 2024
|
| View |
LRV2024-11-04-0476
|
EQUINE ANTI-RABIES IMMUNOGLOBULIN
|
VINRAB
|
BRP-090
|
08AR24035
|
Packaging Lot (Box and Vial): 08AR24035
|
30-Jun-26
|
08 November 2024
|
| View |
LRV2024-11-25-0507
|
EQUINE ANTI-RABIES IMMUNOGLOBULIN
|
VINRAB
|
BRP-090
|
08AR24036
|
Packaging Lot (Box and Vial): 08AR24036
|
30-Jun-26
|
29 November 2024
|
| View |
LRV2024-12-05-0518
|
BACILLUS CALMETTE-GUERIN VACCINE (LIVE, ATTENUATED)
|
SII-ONCO-BCG
|
BR-851
|
1134MA018
|
Packaging Lot (Box and Vial): 1134MA018
|
30-Jun-26
|
11 December 2024
|
| View |
LRV2024-09-10-0418
|
PURIFIED VERO CELL RABIES VACCINE
|
ABHAYRAB
|
BR-629
|
24URAB052
|
Packing Lot (Box and Vial): 24URAB052; (Diluent): SCSVBA0324; (Syringe 24G x 1"): 4087628
|
30-Jun-27
|
16 September 2024
|
| View |
LRV2024-09-24-0437
|
PURIFIED VERO CELL RABIES VACCINE
|
ABHAYRAB
|
BR-629
|
24URAB051
|
Packaging Lot (Box and Vial): 24URAB051; (Diluent): SCSVBA0324; (Syringe 24G x 1"): 4087628
|
30-Jun-27
|
27 September 2024
|
| View |
LRV2024-09-26-0439
|
HUMAN TETANUS IMMUNOGLOBULIN
|
IG TETANO
|
BR-801
|
Q07R2924
|
Packaging Lot (Box and Pre-filled Syringe): Q07R2924
|
30-Jun-27
|
01 October 2024
|
| View |
LRV2024-10-04-0449
|
PURIFIED VERO CELL RABIES VACCINE
|
ABHAYRAB
|
BR-629
|
24URAB058
|
Packaging Lot (Box and Vial): 24URAB058; (Diluent): SCSVBA0424; (Syinge 24G x 1"): 4120042
|
30-Jun-27
|
09 October 2024
|
| View |
LRV2024-10-07-0451
|
PURIFIED VERO CELL RABIES VACCINE
|
ABHAYRAB
|
BR-629
|
24URAB053
|
Packaging Lot (Box and Vial): 24URAB053; (Diluent): SCSVBA0424; (Syinge 24G x 1"): 4120042
|
30-Jun-27
|
11 October 2024
|
| View |
LRV2024-10-17-0463
|
PURIFIED VERO CELL RABIES VACCINE
|
ABHAYRAB
|
BR-629
|
24URAB057
|
Packaging Lot (Box and Vial): 24URAB057; (Diluent): SCSVBA1623; (Syinge): 4120042
|
30-Jun-27
|
21 October 2024
|
| View |
LRV2024-10-18-0470
|
HEPATITIS B VACCINE (rDNA)
|
GENVAC-B
|
BR-567
|
0324Y005E
|
Packaging Lot (Box and Vial): 0324Y005E
|
30-Jun-27
|
29 October 2024
|
| View |
LRV2024-11-08-0483
|
INACTIVATED PURIFIED RABIES VACCINE (VERO-CELL)
|
INDIRAB
|
BR-658
|
62C24027A
|
Packaging Lot (Box and Vial): 62C24027A; (Diluent [Ampoule]): 62F23012A; (Syringe with Needle 25G x 1"): 2641J81
|
30-Jun-27
|
14 November 2024
|